Drug intelligence / Profile preview

escin

Development stage
Phase 4
Lead developer
Sinochem
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical (gel/cream), Intravenous (as Sodium Escinate)
01

Overview

Escin is a natural mixture of triterpenoid saponins isolated from the seeds of the horse chestnut tree (Aesculus hippocastanum). It is the principal active component responsible for most of the medicinal properties attributed to horse chestnut extracts. Escin exhibits anti-inflammatory, venotonic (vein-protecting), anti-edematous (reducing swelling), and vasoprotective effects. Its main active compound is β-escin; other components include α-escin and cryptoescin[1][6][8]. Mechanistically, escin acts by inhibiting hyaluronidase activity (thus protecting capillary permeability), enhancing endothelial nitric oxide synthesis via increased calcium ion permeability in endothelial cells, inducing prostaglandin F2α release, antagonizing serotonin and histamine receptors to reduce vascular permeability and inflammation[1][6]. Clinically it is used primarily for short-term treatment of chronic venous insufficiency and related conditions such as edema or varicose veins. There is also evidence supporting its use in reducing post-operative or traumatic swelling[1][6].

Brand names
Reparil
Other names
七叶皂苷aescusanescin USP/EP/BP
02

Targets

HYAL (Hyaluronidase family (HYAL))

Beyond the preview

Go deeper on escin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on escin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call